All lobbying filings

Vantive US Healthcare LLC

Vantive US Healthcare LLC filed a Q2 report for Vantive US Healthcare LLC on July 21, 2025.

Lobbying for Vantive US Healthcare LLC · Medical Technology Manufacturing

As filed: VANTIVE US HEALTHCARE LLC for VANTIVE US HEALTHCARE LLC.

All filings by Vantive US Healthcare LLC · Everything Vantive US Healthcare LLC has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$450,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

CARLTON KYLE JACKSON

Previously held: Chief of Staff -Rep. Larry Bucshon; Deputy CoS/Leg. Director, Sr. Leg. Assistant, LA, LC-Rep. Jeb Hensarling; Senior Advisor -House Financial Services Committee; CoS, Leg. Director - Rep. Francisco Canseco; Leg. Correspondent -Rep. Randy Neugebauer
ELLASANDRA WALSH HAHN

Previously held: U.S. Senate - Chamber Assistant

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Medicare/Medicaid

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act

Health Issues

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring

Foreign Relations

Issues related to resolving outstanding legal claims

Trade (domestic/foreign)

Issues related to tariffs

Bills named in this filing 1

H.R. 4441
Patient Access to Innovative New Technologies Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.